Smokeless nicotine exposure has no lasting effect on fasting or postglucose circulation leptin in young rats

Metabolic Syndrome and Related Disorders

Volumn 6, Issue 4, 2008, Pages 257-262

  Swislocki, Arthur L M ^a   Fakiri, Zarlasht ^b  

^a VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; LEPTIN; NICOTINE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RAT; SMOKELESS TOBACCO; SYSTOLIC BLOOD PRESSURE; WEIGHT GAIN;

ANIMALS; BLOOD PRESSURE; FASTING; FATTY ACIDS; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; INSULIN; LEPTIN; MALE; NICOTINE; PLACEBOS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 57449093203     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2008.0017     Document Type: Article

References (39)

1. Ball K, Turner S. Smoking and the heart: The basis for action. Lancet 1974;2:822-826.
2. Benowitz NL. Pharmacological aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988;319:1318-1330.
3. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976;295:573-577.
4. Attvall S, Fowelin J, Lager I, Von Schenk H, Smith U. Smoking induces insulin resistance-a potential link with the insulin resistance syndrome. J Int Med 1993;233:327-332.
5. Olofson B, Dahlen G, Nilsson T. Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in patients with angiographically verified coronary artery disease. Eur Heart J 1989;10:77-82.
6. Facchini F, Hollenbeck C, Jeppesen J, Chen I, Reaven G. Insulin resistance and cigarette smoking. Lancet 1992;339:1128-1130.
7. Dube M, Green CR. Methods of collection of smoke for analytical purposes. Recent Adv Tobacco Sci 1982;8:42-102.
8. Siegel D, Benowitz N, Ernster VL, Grady DG, Hauck WW. Smokeless tobacco, cardiovascular risk factors, and nicotine and cotinine levels in professional baseball players. Am J Pub Health 1992;82:417-421.
9. Swislocki ALM, Tsuzuki A, Tait M, Khuu D, Fann K. Smokeless nicotine administration is associated with hypertension but not with a deterioration in glucose tolerance in rats. Metabolism 1997;46:1008-1012.
10. Swislocki ALM. Smokeless nicotine administration does not result in hypertension or a deterioration in glucose tolerance or insulin sensitivity in juvenile rats. Metabolism 2003;52:67-72.
11. Christen AG. Smokeless tobacco usage: a growing and menacing addiction among Hoosier children and young adults. Indiana Med 1996;89:176-180.
12. Coogan PF, Geller A, Adams M. Prevalence and correlates of smokeless tobacco use in a sample of Connecticut students. J Adolesc 2000;23:129-135.
13. Lewis PC, Harrell JS, Deng S, Bradley C. Smokeless tobacco use in adolescents: The Cardiovascular Health in Children (CHIC II) Study. J School Health 1999;69:320-25.
14. Tomar SL, Winn DM, Swango PA, Giovino GA, Kleinman DV. Oral mucosal smokeless lesions among adolescents in the United States. J Dent Res 76:1277-1286.
15. Bailey WJ. Tobacco use by Indiana children and adolescents. Indiana Med 1996;89:138-144.
16. Hanson K, Hatsukami D, Boyle R, Brown S. Minors' access to snuff: purchase outcomes at corporate owned and independently owned convenience stores. Addict Behav 2000;25:289-293.
17. Swislocki A. Insulin resistance and hypertension. Am J Med Sci 1990;300:104-15
18. Bunag RD. Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol 34:279-282.
19. Swislocki A, Eason T. Glucose tolerance and blood pressure are improved in the apontaneously hypertensive rat by ethyl-2-(6-(4-chlorophenoxy)-hexyl) oxirane-2-carboxylate (Etomoxir), an inhibitor of fatty acid oxidation. Am J Hypertens 1994;77:739-744.
20. Migdalof BH. Methods for obtaining drug time course data from individual small laboratory animals: serial microblood sampling and assay. Drug Metab Rev 1976;5:295-310.
21. Swislocki A, Eason T, Kaysen GA. Oral administration of the nitric oxide biosynthesis inhibitor, N-nitro-L-arginine methyl ester (L-NAME), causes hypertension, but not glucose intolerance or insulin resistance, in rats. Am J Hypertens 1995;8:1009-1014
22. Snedecor GW, Cochran WG. Statistical Methods, 8th edition. Iowa State University Press, Ames, IA, 1989.
23. Saah MI, Raygada M, Grunberg NE. Effects of nicotine on body weight and plasma insulin in female and male rats. Life Sci 1994;55:925-931.
24. Perkins KA, Epstein LH, Stiller RL, Marks BL, Jacob RG. Acute effects of nicotine on resting metabolic rate in cigarette smokers. Am J Clin Nutr 1989;50:545-550.
25. Wellman PJ, Marmon MM, Reich S, Ruddle J. Effects of nicotine on body weight, food intake and brown adipose tissue thermogenesis. Pharmacol Biochem Behav 1986;24:1605-1609.
26. Klein S, Goran M. Energy metabolism in response to overfeeding in young adult men. Metabolism 1993;42:1201-1205.
27. Arai K, Kim KS, Kaneko K, Iketani M, Otagiri A, Yamauchi N, Shibasaki T. Nicotine infusion alters leptin and uncoupling protein 1 mRNA expression in adipose tissues of rats. Am J Physiol Endocrinol Metab 2001;280:E867-E876.
28. Perkins KA, Fonte C. Effects of smoking status and smoking cessation on leptin levels. Nicotine Tobacco Res 2002;4;459-466.
29. Oeser A, Goffaux J, Snead W, Carlson MG. Plasma leptin concentrations and lipid profiles during nicotine abstinence. Am J Med Sci 1999;318:152-157.
30. Reseland JE, Mundal HH, Hollung K, Haugen F, Zahid N, Anderssen SA, Drevon CA. Cigarette smoking may reduce plasma leptin concentration via catecholamines. Prostaglandins Leukot Essent Fatty Acids 2005;73:43-49.
31. Miyata G, Meguid MM. Is leptin involved in the acute anorectic effect of nicotine? Nutrition 2000;16:141-142.
32. Sanigorski A, Fahey R, Cameron-Smith D, Collier GR. Nicotine treatment decreases food intake and body weight via a leptin-independent pathway in Psammomys obesus. Diab Obesity Metab 2002;4:346-350.
33. Keim NL, Stern JS, Havel PJ. Relation between circulating leptin concentrations and appetite during a prolonged, moderate energy deficit in women. Am J Clin Nutr 1998;68:794-801.
34. Jang M-H, Shin M-C, Kim K-H, Cho S-Y, Bahn G-H, Kim E-H, Kim C-J. Nicotine administration decreases neuropeptide Y expression and increases leptin receptor expression in the hypothalamus of food-deprived rats. Brain Res 2003;964:311-315.
35. Li MD, Kane JK. Effect of nicotine on the expression of leptin and forebrain leptin receptors in the rat. Brain Res 2003;991:22-31.
36. Chen H, Vlahos R, Bozinovski S, Jones J, Anderson GP, Morris MJ. Effect of short-term cigarette smoke exposure on body weight, appetite and brain neuropeptide Y in mice. Neuropsychopharmacology 2005;30:713-719.
37. Andersson K, Eneroth P, Arner P. Changes in circulating lipid and carbohydrate metabolites following systemic nicotine treatment in healthy men. Int J Obes 1993;17:675-680.
38. Xu Z, Seidler F, Tate C, Garcia S, Slikker W, Slotkin T. Sex-selective hippocampal alterations after adolescent nicotine administration: Effects on neurospecific proteins. Nicotine Tobacco Res 2003;5:955-960.
39. Navarro H, Basta P, Seidler F, Slotkin T. Short-term adolescent nicotine exposure in rats elicits immediate and delayed deficits in T-lymphocyte function: critical periods, patterns of exposure, dose thresholds. Nicotine Tobacco Res 2003;5:859-868.